Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Hepcidin ELISA Kit

Human Hepcidin ELISA Kit, Colorimetric Assay für die Quantifizierung von Human Hepcidin und es wurde in 17+ Publikationen zitiert.
Produktnummer ABIN415120
1.002,22 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 11 bis 15 Werktagen

Kurzübersicht für Hepcidin ELISA Kit (ABIN415120)

Target

Alle Hepcidin (HAMP) ELISA Kits anzeigen
Hepcidin (HAMP) (Hepcidin Antimicrobial Peptide (HAMP))

Reaktivität

  • 18
  • 18
  • 13
  • 8
  • 4
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Nachweismethode

Colorimetric

Methodentyp

Sandwich ELISA

Detektionsbereich

62.5 pg/mL - 4000 pg/mL

Applikation

ELISA

Proben

Plasma, Serum
  • Untere Nachweisgrenze

    62.5 pg/mL

    Verwendungszweck

    The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of Hepc in Serum,Plasma,Biological Fluids

    Analytische Methode

    Quantitative

    Spezifität

    This assay has high sensitivity and excellent specificity for detection of Hepcidin (Hepc).
    No significant cross-reactivity or interference between Hepcidin (Hepc) and analogues was observed.

    Kreuzreaktivität (Details)

    No significant cross-reactivity or interference between Hepcidin (Hepc) and analogues was observed.

    Sensitivität

    < 26.4 pg/mL

    Bestandteile

    • Pre-coated, 96-well strip plate
    • Plate sealer
    • Standard
    • Standard Diluent
    • Detection Reagent A
    • Assay Diluent A
    • Detection Reagent B
    • Assay Diluent B
    • TMB Substrate
    • Stop Solution
    • Wash Buffer (30X)
    • Instruction manual

    Benötigtes Material

    • Microplate reader with 450 nm filter.
    • Precision single or multi-channel pipettes and disposable tips.
    • Eppendorf Tubes for diluting samples.
    • Deionized or distilled water.
    • Absorbent paper for blotting the microtiter plate.
    • Container for Wash Solution
  • Applikationshinweise

    • Limited by the current condition and scientific technology, we cannot completely conduct the comprehensive identification and analysis on the raw material provided by suppliers. So there might be some qualitative and technical risks to use the kit.
    • The final experimental results will be closely related to validity of the products, operation skills of the end users and the experimental environments. Please make sure that sufficient samples are available.
    • Kits from different batches may be a little different in detection range, sensitivity and color developing time.
    • Do not mix or substitute reagents from one kit lot to another. Use only the reagents supplied by manufacturer.
    • Protect all reagents from strong light during storage and incubation. All the bottle caps of reagents should be covered tightly to prevent the evaporation and contamination of microorganism.
    • There may be some foggy substance in the wells when the plate is opened at the first time. It will not have any effect on the final assay results. Do not remove microtiter plate from the storage bag until needed.
    • Wrong operations during the reagents preparation and loading, as well as incorrect parameter setting for the plate reader may lead to incorrect results. A microplate plate reader with a bandwidth of 10nm or less and an optical density range of 0-3 O.D. or greater at 450 ± 10nm wavelength is acceptable for use in absorbance measurement. Please read the instruction carefully and adjust the instrument prior to the experiment.
    • Even the same operator might get different results in two separate experiments. In order to get better reproducible results, the operation of every step in the assay should be controlled. Furthermore, a preliminary experiment before assay for each batch is recommended.
    • Each kit has been strictly passed Q.C test. However, results from end users might be inconsistent with our in-house data due to some unexpected transportation conditions or different lab equipments. Intra-assay variance among kits from different batches might arise from above factors, too.
    • Kits from different manufacturers for the same item might produce different results, since we have not compared our products with other manufacturers.

    Kommentare

    Information on standard material:
    The standard might be recombinant protein or natural protein, that will depend on the specific kit. Moreover, the expression system is E.coli or yeast or mammal cell. There is 0.05% proclin 300 in the standard as preservative.

    Information on reagents:
    The stop solution used in the kit is sulfuric acid with concentration of 1 mol/L. And the wash solution is TBS. The standard diluent contains 0.02 % sodium azide, assay diluent A and assay diluent B contain 0.01% sodium azide. Some kits can contain is BSA in them.

    Information on antibodies:
    The provided antibodies and their host vary in different kits.

    Probenmenge

    100 μL

    Testdauer

    3 h

    Plattentyp

    Pre-coated

    Protokoll

    1. Prepare all reagents, samples and standards;
    2. Add 100µL standard or sample to each well. Incubate 2 hours at 37°C;
    3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
    4. Aspirate and wash 3 times;
    5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
    6. Aspirate and wash 5 times;
    7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
    8. Add 50µL Stop Solution. Read at 450nm immediately.

    Testpräzision

    Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Hepcidin (Hepc) were tested 20 times on one plate, respectively.
    Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Hepcidin (Hepc) were tested on 3 different plates, 8 replicates in each plate.
    CV(%) = SD/meanX100
    Intra-Assay: CV<10%
    Inter-Assay: CV<12%

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Vorsichtsmaßnahmen

    The Stop Solution suggested for use with this kit is an acid solution. Wear eye, hand, face, and clothing protection when using this material.

    Handhabung

    The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5 % within the expiration date under appropriate storage condition.
    To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

    Lagerung

    4 °C

    Informationen zur Lagerung

    • For unopened kit: All the reagents should be kept according to the labels on vials. The Standard, Detection Reagent A, Detection Reagent B and the 96-well strip plate should be stored at -20°C upon receipt while the others should be at 4°C.
    • For opened kit: When the kit is opened, the remaining reagents still need to be stored according to the above storage condition. Besides, please return the unused wells to the foil pouch containing the desiccant pack, and reseal along entire edge of zip-seal.
      Note: It is highly recommended to use the remaining reagents within 1 month provided this is within the expiration date of the kit.
    • For ELISA kit, 1 day storage at 37°C can be considered as 2 months at 4°C, which means 3 days at 37°C equaling 6 months at 4°C.

    Haltbarkeit

    6 months
  • Gromadzka, Wierzbicka, Litwin, Przybyłkowski: "Difference in iron metabolism may partly explain sex-related variability in the manifestation of Wilson's disease." in: Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), Vol. 62, pp. 126637, (2020) (PubMed).

    Zhu, He, Jing, Ma, Li, Yang, Jin, Chen: "Hepcidin and iron metabolism associated with cardiometabolic risk factors in children: A case-control study." in: Nutrition, metabolism, and cardiovascular diseases : NMCD, Vol. 26, Issue 6, pp. 525-33, (2016) (PubMed).

    Shu, Jing, Lv, Xie, Xu, Wu: "Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis." in: European journal of haematology, Vol. 94, Issue 1, pp. 67-73, (2015) (PubMed).

    Okyay, Y?ld?r?r: "Assessment of serum hepcidin levels in patients with non-ST elevation myocardial infarction." in: Anatolian journal of cardiology, Vol. 15, Issue 2, pp. 164-5, (2015) (PubMed).

    Paköz, Çekiç, Arabul, Sar?ta? Yüksel, ?pek, Vatansever, Ünsal: "An Evaluation of the Correlation between Hepcidin Serum Levels and Disease Activity in Inflammatory Bowel Disease." in: Gastroenterology research and practice, Vol. 2015, pp. 810942, (2015) (PubMed).

    Andrade, Pavan Kumar, Sridhar, Banurekha, Jawahar, Nutman, Sher, Babu: "Heightened plasma levels of heme oxygenase-1 and tissue inhibitor of metalloproteinase-4 as well as elevated peripheral neutrophil counts are associated with TB-diabetes comorbidity." in: Chest, Vol. 145, Issue 6, pp. 1244-54, (2014) (PubMed).

    Yegin, Iyidir, Demirta?, Suyan?, Yetkin, Pa?ao?lu, Ilhan, Sucak: "The interplay among iron metabolism, endothelium and inflammatory cascade in dysmetabolic disorders." in: Journal of endocrinological investigation, (2014) (PubMed).

    Pardanani, Finke, Abdelrahman, Lasho, Tefferi: "Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosis." in: American journal of hematology, Vol. 88, Issue 4, pp. 312-6, (2013) (PubMed).

    Gun Eryilmaz, Tavil, Turan, Yumusak, Doganay, Uzunlar, Akar, Eyi: "Hepcidin and erythropoietin measurements in the cord blood of neonates with meconium-stained amniotic fluid." in: The journal of obstetrics and gynaecology research, Vol. 39, Issue 1, pp. 175-9, (2013) (PubMed).

    Kotta-Loizou, Vassilaki, Pissas, Kakkanas, Bakiri, Bartenschlager, Mavromara: "Hepatitis C virus core+1/ARF protein decreases hepcidin transcription through an AP1 binding site." in: The Journal of general virology, Vol. 94, Issue Pt 7, pp. 1528-34, (2013) (PubMed).

    Wang, Cheng, Jiang, Jiao: "The effect of hepatitis B virus infection on hepcidin expression in hepatitis B patients." in: Annals of clinical and laboratory science, Vol. 43, Issue 2, pp. 126-34, (2013) (PubMed).

    Cheng, Sun, Jiang, Tang, Jiao: "Hepcidin expression in patients with acute leukaemia." in: European journal of clinical investigation, Vol. 42, Issue 5, pp. 517-25, (2012) (PubMed).

    Theurl, Schroll, Nairz, Seifert, Theurl, Sonnweber, Kulaksiz, Weiss: "Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo." in: Haematologica, Vol. 96, Issue 12, pp. 1761-9, (2012) (PubMed).

    Zhang, He, Dai, Xiong, Zheng, Zhou, Li, Sun, Luo, Cheng, Qin, Tian, Chen, Yu, Jin, Guo, Li, Wang, Peng, Zhang, Zhang, Chen, Wang, Li, Li, Lu, Ye, de Jong, Xu: "Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome." in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 54, Issue 4, pp. 527-33, (2012) (PubMed).

    Piednoir, Quesnel, Nardelli, Leçon, Bouadma, Lasocki, Philip, Mailleux, Soler, Crestani, Dehoux: "Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: role of platelet-derived growth factor pathway*." in: Critical care medicine, Vol. 40, Issue 7, pp. 2041-9, (2012) (PubMed).

    Shin, Chung, Joe, Pae, Chang, Cho, Ryter, Chung: "Pretreatment with CO-releasing molecules suppresses hepcidin expression during inflammation and endoplasmic reticulum stress through inhibition of the STAT3 and CREBH pathways." in: Blood, Vol. 119, Issue 11, pp. 2523-32, (2012) (PubMed).

    Cheng, Jiao, Wang, Lin, Cai: "Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia." in: Clinical and experimental medicine, Vol. 11, Issue 1, pp. 33-42, (2011) (PubMed).

  • Target Alle Hepcidin (HAMP) ELISA Kits anzeigen

    Hepcidin (HAMP) (Hepcidin Antimicrobial Peptide (HAMP))

    Andere Bezeichnung

    Hepc

    Hintergrund

    HAMP, HFE2B, PLTR, LEAP1, Hepcidin Antimicrobial Peptide, Liver-expressed antimicrobial peptide 1, Putative liver tumor regressor

    UniProt

    P81172

    Pathways

    Hormone Activity, Transition Metal Ion Homeostasis
Sie sind hier:
Chat with us!